Amylyx Director's Stock Purchase Signals Internal Confidence Amid Biotech Developments
Director Karen Firestone recently acquired a significant block of common stock in Amylyx Pharmaceuticals, Inc. This insider transaction occurs while the company's stock shows strong year-over-year performance gains, even as recent financial reporting detailed an earnings miss for Q1 2026 and increased operating expenses.